Effect of Calamintha officinalis on Vascular Contractility and Angiotensinconverting Enzyme-2
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
AIMS: The study aimed to assess the antihypertensive activity of Calamintha officinalis.
BACKGROUND: Calamintha officinalis (CO) is a medicinal and aromatic herb as well as an antihypertensive plant that is widely used for its medicinal properties in several regions.
OBJECTIVE: This study aimed to evaluate the effect of the aqueous extract of Calamintha officinalis (AECO) on vasorelaxant activity and arterial blood pressure under normal and hypertensive states in rats. Additionally, the effect of AECO on vascular angiotensin-converting enzyme 2 (ACE-2) was assessed.
METHODS: In the current study, AECO (100 mg/Kg) was prepared, and its antihypertensive ability was assessed in L-NG-Nitro arginine methyl ester (L-NAME)-induced hypertensive rats. Blood pressure and heart rate were recorded for 6 h for the acute experiment and during seven days for the subchronic treatment.
RESULTS: The results indicated that AECO reduced the systolic, diastolic, and mean arterial blood pressure in hypertensive rats. In addition, the study showed that AECO exerts a vasorelaxant ability through the sGC-cGMP induction pathway, vascular cyclooxygenase pathway, and the opening of K+ channels. However, AECO had no inhibitory effect on aortic ACE-2.
CONCLUSION: The study illustrates the beneficial action of AECO as an antihypertensive and vasorelaxant agent.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Cardiovascular & hematological agents in medicinal chemistry - 20(2022), 3 vom: 12., Seite 219-236 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Azzane, Amine [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 23.09.2022 Date Revised 17.10.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1871525720666220302125242 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337675171 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337675171 | ||
| 003 | DE-627 | ||
| 005 | 20231225234945.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1871525720666220302125242 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1125.xml |
| 035 | |a (DE-627)NLM337675171 | ||
| 035 | |a (NLM)35236273 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Azzane, Amine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of Calamintha officinalis on Vascular Contractility and Angiotensinconverting Enzyme-2 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.09.2022 | ||
| 500 | |a Date Revised 17.10.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a AIMS: The study aimed to assess the antihypertensive activity of Calamintha officinalis | ||
| 520 | |a BACKGROUND: Calamintha officinalis (CO) is a medicinal and aromatic herb as well as an antihypertensive plant that is widely used for its medicinal properties in several regions | ||
| 520 | |a OBJECTIVE: This study aimed to evaluate the effect of the aqueous extract of Calamintha officinalis (AECO) on vasorelaxant activity and arterial blood pressure under normal and hypertensive states in rats. Additionally, the effect of AECO on vascular angiotensin-converting enzyme 2 (ACE-2) was assessed | ||
| 520 | |a METHODS: In the current study, AECO (100 mg/Kg) was prepared, and its antihypertensive ability was assessed in L-NG-Nitro arginine methyl ester (L-NAME)-induced hypertensive rats. Blood pressure and heart rate were recorded for 6 h for the acute experiment and during seven days for the subchronic treatment | ||
| 520 | |a RESULTS: The results indicated that AECO reduced the systolic, diastolic, and mean arterial blood pressure in hypertensive rats. In addition, the study showed that AECO exerts a vasorelaxant ability through the sGC-cGMP induction pathway, vascular cyclooxygenase pathway, and the opening of K+ channels. However, AECO had no inhibitory effect on aortic ACE-2 | ||
| 520 | |a CONCLUSION: The study illustrates the beneficial action of AECO as an antihypertensive and vasorelaxant agent | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ACE-2 | |
| 650 | 4 | |a Calamintha officinalis | |
| 650 | 4 | |a L-NAME | |
| 650 | 4 | |a antihypertensive effect | |
| 650 | 4 | |a cardiovascular diseases | |
| 650 | 4 | |a hypertension | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 650 | 7 | |a Plant Extracts |2 NLM | |
| 650 | 7 | |a Vasodilator Agents |2 NLM | |
| 650 | 7 | |a Prostaglandin-Endoperoxide Synthases |2 NLM | |
| 650 | 7 | |a EC 1.14.99.1 |2 NLM | |
| 650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a NG-Nitroarginine Methyl Ester |2 NLM | |
| 650 | 7 | |a V55S2QJN2X |2 NLM | |
| 700 | 1 | |a Azzaoui, Bouchra |e verfasserin |4 aut | |
| 700 | 1 | |a Akdad, Mourad |e verfasserin |4 aut | |
| 700 | 1 | |a Bouadid, Ismail |e verfasserin |4 aut | |
| 700 | 1 | |a Eddouks, Mohamed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular & hematological agents in medicinal chemistry |d 2006 |g 20(2022), 3 vom: 12., Seite 219-236 |w (DE-627)NLM161201482 |x 1875-6182 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2022 |g number:3 |g day:12 |g pages:219-236 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1871525720666220302125242 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2022 |e 3 |b 12 |h 219-236 | ||